✦ LIBER ✦

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)

✍ Scribed by J.-H. Saurat; G. Stingl; L. Dubertret; K. Papp; R.G. Langley; J.-P. Ortonne; K. Unnebrink; M. Kaul; A. Camez; for the CHAMPION Study Investigators

Book ID: 108669801
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 278 KB
Volume: 158
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.2007.08315.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of infliximab vs. me

Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)

✍ J. Barker; M. Hoffmann; G. Wozel; J.-P. Ortonne; H. Zheng; H. van Hoogstraten; K 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB

Adalimumab in Japanese patients with mod

Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study

✍ Akihiko ASAHINA; Hidemi NAKAGAWA; Takafumi ETOH; Mamitaro OHTSUKI; THE ADALIMUMA 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 490 KB

Efficacy and safety of adalimumab in pat

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Désirée van der Heijde; Alan Kivitz; Michael H. Schiff; Joachim Sieper; Ben A. C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Efficacy and safety of bifeprunox in pat

Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study

✍ Daniel E. Casey; Earl E. Sands; Jens Heisterberg; Hwa-Ming Yang 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 291 KB

The efficacy and safety of rituximab in

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial

✍ Paul Emery; Roy Fleischmann; Anna Filipowicz-Sosnowska; Joy Schechtman; Leszek S 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 2 views

A phase IIIb, multicentre, randomized, d

A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study

✍ D. Thaçi; J.-P. Ortonne; S. Chimenti; P.-D. Ghislain; P. Arenberger; K. Kragball 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB